Trend Analysis of Indicator Medicine Availability Based on e-Monev Data at the Jembatan Kecil Community Health Center in 2025: Analisis Tren Ketersediaan Obat Indikator Berdasarkan Data e-Monev Obat di Puskesmas Jembatan Kecil Tahun 2025

Syaripah Ulandari; Denny Ardhianto; Alya Nur Amilia

doi:10.70392/jrn.v3i2.5563

Authors

Syaripah Ulandari Universitas Lampung Author
Denny Ardhianto Universitas Lampung Author
Alya Nur Amilia Sekolah Tinggi Ilmu Kesehatan Samarinda Author

DOI:

https://doi.org/10.70392/jrn.v3i2.5563

Keywords:

drug availability, e-Monev Obat, Indicator medicines, Community health centers

Abstract

Drug availability is a key indicator of the quality of pharmaceutical services at community health centers that supports the continuity of health care. Monitoring through the electronic Drug Monitoring and Evaluation (e-Monev Obat) application can be used to evaluate the management of indicator drug inventories. This study aims to analyze the availability of indicator medications based on e-Monev Obat data at the Jembatan Kecil Community Health Center in 2025. The study employed a quantitative descriptive design with a retrospective approach to secondary e-Monev Obat data from January through December 2025. All 40 indicator medications were analyzed using total sampling. Descriptive analysis was conducted to describe the monthly percentage of drug availability, availability trends, and the frequency of unavailability of indicator drugs. The results showed that the percentage of indicator drug availability increased from 72.5% in January to 97.5% in December, with an average availability rate for 2025 of 85.8%. The drugs with the highest frequency of unavailability were glimepiride (12 months), furosemide (9 months), oxytocin (8 months), omeprazole (7 months), and haloperidol (6 months). It was concluded that the unavailability of indicator drugs at the Jembatan Kecil Community Health Center improved throughout 2025; however, some indicator drugs continued to experience recurring shortages, necessitating strengthened planning of drug requirements, procurement, and inventory control to ensure the sustained availability of drugs.

References

Peraturan Menteri Kesehatan Republik Indonesia Nomor 19 Tahun 2024 tentang Penyelenggaraan Pusat Kesehatan Masyarakat. 2024. Jakarta:Kementerian Kesehatan Republik Indonesia.

Peraturan Menteri Kesehatan Republik Indonesia Nomor 74 Tahun 2016 tentang Standar Pelayanan Kefarmasian di Puskesmas. 2016. Jakarta:Kementerian Kesehatan Republik Indonesia.

World Health Organization. The Selection and Use of Essential Medicines: WHO Model List of Essential Medicines. 2023. Geneva: World Health Organization.

Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia Tahun 2023. 2023. Jakarta: Kementerian Kesehatan RI.

Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/6477/2021 tentang Daftar Obat Esensial Nasional. 2021. Jakarta: Menteri Kesehatan Republik Indonesia.

Fanda, R., Probandari, A., Yuniar, Y., Hendarwan, H., Trisnantoro, L., Jongeneel, N., Kok, M .The availability of essential medicines in primary health centres in Indonesia: achievements and challenges across the archipelago. The Lancet Regional Health - Southeast Asia 2024, 22, 100345. https://doi.org/10.1016/j.lansea.2023.100345.

Jasin, M.R., Madania, M., Tuloli, S.T. Tingkat Ketersediaan Obat di Puskesmas Kota Selatan dan Puskesmas Piloloda’a Tahun 2024. OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan 2026, 4(3), 13-26. https://doi.org/10.61132/obat.v4i3.2231

Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/2015/2023 tentang Petunjuk Teknis Integrasi Pelayanan Kesehatan Primer. 2023. Jakarta:Kementerian Kesehatan Republik Indonesia.

Badan Pusat Statistik. Metadata Indikator Statistik: Persentase Ketersediaan Obat Esensial di Kabupaten/Kota. 2024. tersedia pada: https://sirusa.web.bps.go.id/metadata/indikator/49274?utm_source

Peraturan Presiden Republik Indonesia Nomor 12 Tahun 2025 tentang Rencana Pembangunan Jangka Menengah Nasional Tahun 2025-2029. 2025. Jakarta: Kementerian Kesehatan Republik Indonesia.

Zebua, M.M., Fitri, W., Fikrih, R,. Analisis Ketersediaan Obat Indikator di Wilayah Kerja Puskesmas Kecamatan Medan Area Tahun 2022. Jurnal Farmanesia 2023; 10(2), 38-40. doi:10.51544/jf.v10i2.4589

Fanda, R,B., Probandari, A., Yuniar, Y., van Gurp, M., van der Hoeven, W.G., Hendrawan, h., Trisnantoro, L., Kok, M.O. Local systems, local solutions: which factors drive essential medicine availability in public health facilities across Indonesia?. BMJ Global Health 2026, 11(2), e019616. doi:10.1136/bmjgh-2025-019616

Zhang, M., Zou, K., Liu, Z., Liu, D., Wang, X., Shi, Y., Chen, Z., Cheng, X., Lang, B., Li, H., Zeng, L., Tang, Y., Zhao, S., Jiang, Y., Choonara, I., Zhang, L.. Availability of essential medicines, progress and regional distribution in China: a systematic review and meta-analysis. Frontier in Public Health 2023, 11, 1149838. doi:10.3389/fpubh.2023.1149838

Mahmić-Kaknjo, M., Jeličić-Kadić, A., Utrobičić, A., Chan, K., Bero, L., Marušić, A. Essential medicines availability is still suboptimal in many countries: a scoping review. J Clin Epidemiol 2018, 98, 41-52. doi:10.1016/j.jclinepi.2018.02.006

Olaniran, A., Briggs, J., Pradhan, A., Bogue, E., Schireiber, B., Dini, H.S., Hurkchand, H., Ballard, M. Stock-outs of essential medicines among community health workers (CHWs) in low- and middle-income countries (LMICs): a systematic literature review of the extent, reasons, and consequences. Human Resources for Health 2022, 20(1), 58. doi:10.1186/s12960-022-00755-8

Mbonyinshuti, F., Takarinda, K.C., Ade, S., Manzi, m., Iradakunda, P.G., Kabatende, J., Habiyaremye, T., Kayumba, P.C. Evaluating the availability of essential drugs for hypertension, diabetes and asthma in rural Rwanda, 2018. Public Health Action 2021, 11(1), 5-11. doi:10.5588/pha.20.0033

Zuma, Sibusiso, M. Assessment of medicine stock-out challenges in public health services. Sabinet African Journals 2022, 10(1), 578.

AlRuthia, Y.S., AlKofide, H., AlAjmi, R., Bakhi, B., Alghamdi, A., AlNasser, A., Alayed, A., Alshamari, M., Alsuhaibani, D., Alathbah, A.. Drug shortages in large hospitals in Riyadh: a cross-sectional study. Ann Saudi Med 2017, 37(5), 375-385. doi:10.5144/0256-4947.2017.375

Zwaida, T.A., Beauregard, Y., Elarroudi, K. Comprehensive literature review about drug shortages in the canadian hos-pital's pharmacy supply chain. In 2019 International Conference on Engineering, Science, and Industrial Applications (ICESI) 2019, 1-5. doi: 10.1109/ICESI.2019.8863026.

Jenzer, H., Sadeghi, L., Maag, P., Scheidegger-Balmer, F., Uhlmann, K., Grösser, S. The European Medicines Shortages Research Network and Its Mission to Strategically Debug Disrupted Pharmaceutical Supply Chains. In A. P. Barbosa-Povoa, H. Jenzer, & J. L. de Miranda (Eds.), Pharmaceutical Supply Chains: Medicines Shortages 2019, 1–22. Springer. https://doi.org/10.24451/arbor.18636

Kefale, A.T., Shebo, H.H. Availability of essential medicines and pharmaceutical inventory management practice at health centers of Adama town, Ethiopia. BMC Health Serv Res 2019, 19(1), 254. doi:10.1186/s12913-019-4087-0